Liberum Capital announced Plant Health Care PLC (LON:PHC), keeping its stock price target at 45.00GBX today
- Updated: September 25, 2016
In a report released on Monday September 26, 2016 Liberum Capital hold steady the stock price target of Plant Health Care PLC (LON:PHC) from 45.00GBX to 45.00GBX reporting a possible upside of 1.06%.
Previously on 9/14/2016, Liberum Capital reported on Plant Health Care PLC (LON:PHC) held steady the target price at 45.00GBX. At the time, this indicated a possible upside of 1.25%.
Just yesterday Plant Health Care PLC (LON:PHC) traded 2.09% higher at 21.88GBX. Plant Health Care PLC’s 50-day moving average is 21.67GBX and its 200-day moving average is 38.65GBX. The last closing price is down -41.89% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 64,109 shares of PHC traded hands, down from an average trading volume of 108,100
Recent Performance Chart
Plant Health Care PLC has 52 week low of 13.62GBX and a 52 week high of 95.00GBX and has a market capitalization of 0 GBX.
In addition to Liberum Capital reporting its stock price target, a total of 1 broker has issued a research note on the company. The average stock price target is 176.33GBX with 1 broker rating the stock a strong buy, 0 brokers rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
Brief Synopsis On Plant Health Care PLC (LON:PHC)
Plant Health Care plc provides agricultural biological products and technology solutions. The Company's segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products. Its products are categorized as biofertilizers and biostimulants. Its product portfolio is mainly based on Harpin technology. The Commercial business sells its products across the world through distributors and distributes complementary third-party products in Mexico. The Commercial business includes geographic segments, such as the Americas, Mexico and Rest of World. The New Technology segment is focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The PREtec platform identifies families of peptides that provide crop treatment options for growers that are complementary to existing agricultural technologies and practices.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.